Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Gastric Cancer

  Free Subscription


04.05.2025

1 Am J Gastroenterol
5 Anticancer Res
2 BMC Cancer
3 BMC Gastroenterol
1 BMC Surg
2 Br J Cancer
2 Cancer Lett
2 Cancer Res
2 Eur J Surg Oncol
1 Gastrointest Endosc
1 J Gastroenterol Hepatol
3 J Surg Oncol
1 Lancet Oncol
1 Oncol Rep
1 Surgery


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. JOVE A, Lin C, Hwang JH, Balasubramanian V, et al
    Serum Gastrin Levels Are Associated With Prevalent Neuroendocrine Tumors in Autoimmune Metaplastic Atrophic Gastritis.
    Am J Gastroenterol. 2025;120:1140-1143.
    PubMed         Abstract available


    Anticancer Res

  2. JANG BI, Jung JY, Koh SA, Park YE, et al
    MAP17 as a Mediator of HGF-induced Proliferation and Invasion in Gastric Cancer.
    Anticancer Res. 2025;45:2011-2024.
    PubMed         Abstract available

  3. LAI LW, Yamashita T, Otsuka K, Saito A, et al
    Rare Upper Mediastinal Oligometastasis from Early Esophagogastric Adenocarcinoma: A Case Report.
    Anticancer Res. 2025;45:2109-2114.
    PubMed         Abstract available

  4. ZHOU N, Yuan Y, Lin H, Wang J, et al
    Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer.
    Anticancer Res. 2025;45:1935-1951.
    PubMed         Abstract available

  5. KANG M, Kim KJ, Sung JH, Nam M, et al
    Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With PIK3CA Mutations and Overcoming Strategies.
    Anticancer Res. 2025;45:1877-1896.
    PubMed         Abstract available

  6. HOJO Y, Tomita T, Igeta M, Murakami M, et al
    Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer.
    Anticancer Res. 2025;45:2091-2102.
    PubMed         Abstract available


    BMC Cancer

  7. LIU G, Cao S, Liu X, Tian Y, et al
    Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG202
    BMC Cancer. 2025;25:776.
    PubMed         Abstract available

  8. RAFIEPOOR H, Banoei MM, Ghorbankhanloo A, Muhammadnejad A, et al
    Exploring the potential of machine learning in gastric cancer: prognostic biomarkers, subtyping, and stratification.
    BMC Cancer. 2025;25:809.
    PubMed         Abstract available


    BMC Gastroenterol

  9. ZHANG X, Lin Z, Xu B, Ma C, et al
    Unveiling gastric precancerous stages: metabolomic insights for early detection and intervention.
    BMC Gastroenterol. 2025;25:318.
    PubMed         Abstract available

  10. QI TT, Zhou SJ, Yu Z, Li Y, et al
    Unveiling the heterogeneity and immunotherapy potency of tumor-associated neutrophils in the tumor microenvironment of gastric cancer.
    BMC Gastroenterol. 2025;25:303.
    PubMed         Abstract available

  11. LUO J, Zhu P, Zhou S
    Association between the red blood cell distribution width-to-albumin ratio and risk of colorectal and gastric cancers: a cross-sectional study using NHANES 2005-2018.
    BMC Gastroenterol. 2025;25:316.
    PubMed         Abstract available


    BMC Surg

  12. BACK J, Sallinen V, Bonsdorff A, Kokkola A, et al
    Short- and long-term outcomes after perioperative EOX therapy versus upfront surgery for gastric cancer: a single-centre propensity score-matched cohort study.
    BMC Surg. 2025;25:184.
    PubMed         Abstract available


    Br J Cancer

  13. SUN M, Gu Y, Wang J, Zhang Z, et al
    Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer.
    Br J Cancer. 2025 Apr 25. doi: 10.1038/s41416-025-03002.
    PubMed         Abstract available

  14. GROEN-VAN SCHOOTEN TS, Cabeza-Segura M, Ferreira RM, Martinez-Ciarpaglini C, et al
    Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence.
    Br J Cancer. 2025;132:783-792.
    PubMed         Abstract available


    Cancer Lett

  15. LI W, Wei H, Liu J, Zhao Z, et al
    Exosomal Biglycan Promotes Gastric Cancer Progression via M2 Polarization and CXCL10-Mediated JAK/STAT1 Activation.
    Cancer Lett. 2025 Apr 29:217758. doi: 10.1016/j.canlet.2025.217758.
    PubMed         Abstract available

  16. SONG S, Fan Y, Zou G, Huo L, et al
    KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB.
    Cancer Lett. 2025;621:217695.
    PubMed         Abstract available


    Cancer Res

  17. KUAI X, Li L, Chen R, Wang K, et al
    Correction: SCFFBXW7/GSK3beta-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.
    Cancer Res. 2025;85:1739.
    PubMed        

  18. QIU B, Zheng Y, Liu S, Song R, et al
    Multi-task Deep Learning Based on Longitudinal CT Images Facilitates Prediction of Lymph Node Metastasis and Survival in Chemotherapy-Treated Gastric Cancer.
    Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-4190.
    PubMed         Abstract available


    Eur J Surg Oncol

  19. CHEN J, Hu K, Lu J, Pan H, et al
    Optimizing surgical timing following neoadjuvant therapy for gastric Cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110063.
    PubMed         Abstract available

  20. LI H, Huang J, Liu K, Liu J, et al
    ChatGPT-4o outperforms gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110096.
    PubMed         Abstract available


    Gastrointest Endosc

  21. SINGH AD, Gupta A, Mehta N, Heald B, et al
    Corrigendum to Occurrence of gastric cancer in patients with juvenile polyposis syndrome: a systematic review and meta-analysis. Gastrointestinal Endoscopy. Volume 97, Issue 3, March 2023, Pages 407-414.e1.
    Gastrointest Endosc. 2025 Apr 30:S0016-5107(25)01598.
    PubMed        


    J Gastroenterol Hepatol

  22. WANG M, Guo Y, Xu Y, Yu Y, et al
    Unraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response.
    J Gastroenterol Hepatol. 2025 Apr 28. doi: 10.1111/jgh.16987.
    PubMed         Abstract available


    J Surg Oncol

  23. WANG YC, Liao YJ, Lin WT, Liao SC, et al
    Assessment of Endoscopic Ultrasound for Predicting Preoperative T Staging in Patients With Gastric Adenocarcinoma.
    J Surg Oncol. 2025;131:411-416.
    PubMed         Abstract available

  24. LI MX, Lopez-Aguiar AG, Poultsides G, Rocha F, et al
    Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors.
    J Surg Oncol. 2025;131:473-480.
    PubMed         Abstract available

  25. SONG Y, Chen E, Chiang YJ, Yao JC, et al
    Classification of Gastric Neuroendocrine Tumors and Associations With Survival.
    J Surg Oncol. 2025;131:204-211.
    PubMed         Abstract available


    Lancet Oncol

  26. KELSEN D
    Docetaxel as part of first-line chemotherapy for gastric cancer.
    Lancet Oncol. 2025 Apr 23:S1470-2045(25)00154.
    PubMed        


    Oncol Rep

  27. LI Y, Wang K, Wei Y, Yao Q, et al
    [Retracted] lncRNA?MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR?29a?3p/HDAC4 axis.
    Oncol Rep. 2025;53:69.
    PubMed         Abstract available


    Surgery

  28. FUJIMOTO D, Taniguchi K, Takashima J, Kobayashi H, et al
    Possibility of preventing intra-abdominal infection by lymph node mapping with indocyanine green in robotic gastrectomy.
    Surgery. 2025;181:109212.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.